company background image
BAX logo

Baxter International WBAG:BAX Stock Report

Last Price

€38.20

Market Cap

€19.7b

7D

-0.4%

1Y

3.7%

Updated

26 Mar, 2024

Data

Company Financials +

Baxter International Inc.

WBAG:BAX Stock Report

Market Cap: €19.7b

BAX Stock Overview

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.

BAX fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance0/6
Financial Health2/6
Dividends2/6

Baxter International Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Baxter International
Historical stock prices
Current Share PriceUS$38.20
52 Week HighUS$44.35
52 Week LowUS$30.05
Beta0.62
1 Month Change-2.92%
3 Month Change10.25%
1 Year Change3.72%
3 Year Change-47.47%
5 Year Change-47.43%
Change since IPO-35.49%

Recent News & Updates

Recent updates

Shareholder Returns

BAXAT Medical EquipmentAT Market
7D-0.4%-0.8%0.9%
1Y3.7%14.2%6.9%

Return vs Industry: BAX underperformed the Austrian Medical Equipment industry which returned 12.8% over the past year.

Return vs Market: BAX underperformed the Austrian Market which returned 7.4% over the past year.

Price Volatility

Is BAX's price volatile compared to industry and market?
BAX volatility
BAX Average Weekly Movement3.4%
Medical Equipment Industry Average Movement5.5%
Market Average Movement3.3%
10% most volatile stocks in AT Market5.0%
10% least volatile stocks in AT Market1.6%

Stable Share Price: BAX has not had significant price volatility in the past 3 months.

Volatility Over Time: BAX's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
193160,000Joe Almeidahttps://www.baxter.com

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

Baxter International Inc. Fundamentals Summary

How do Baxter International's earnings and revenue compare to its market cap?
BAX fundamental statistics
Market cap€19.65b
Earnings (TTM)-€70.17m
Revenue (TTM)€13.68b

1.4x

P/S Ratio

-278.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BAX income statement (TTM)
RevenueUS$14.81b
Cost of RevenueUS$9.15b
Gross ProfitUS$5.66b
Other ExpensesUS$5.74b
Earnings-US$76.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.15
Gross Margin38.22%
Net Profit Margin-0.51%
Debt/Equity Ratio162.1%

How did BAX perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

-772%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.